Skip to content
10-K

Annual Report

Eucrates Biomedical Acquisition Corp.

0001410578-23-000637

← back to feed
Filed
Apr 13, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Apr 13, 2023 4.21M sh
Stock Repurchased FY 2022 · Dec 31, 2022 $93.19M
Operating Cash Flow FY 2022 · Dec 31, 2022 −$630.29K
Operating Cash Flow FY 2022 · Dec 31, 2021 −$502.11K
Cash And Equivalents FY 2022 · Dec 31, 2022 $18.87K
Cash And Equivalents FY 2022 · Dec 31, 2021 $49.16K
Stockholders Equity FY 2022 · Dec 31, 2022 −$3.72M
Stockholders Equity FY 2022 · Dec 31, 2021 −$5.49M
Current Liabilities FY 2022 · Dec 31, 2022 $65.14K
Current Liabilities FY 2022 · Dec 31, 2021 $38.46K
Total Liabilities FY 2022 · Dec 31, 2022 $3.95M
Total Liabilities FY 2022 · Dec 31, 2021 $5.8M
Current Assets FY 2022 · Dec 31, 2022 $132.2K
Current Assets FY 2022 · Dec 31, 2021 $264.16K
Total Assets FY 2022 · Dec 31, 2022 $12.49M
Total Assets FY 2022 · Dec 31, 2021 $105.11M
Net Income FY 2022 · Dec 31, 2022 $2.42M
Net Income FY 2022 · Dec 31, 2021 $3.82M
Operating Income FY 2022 · Dec 31, 2022 −$698.58K
Operating Income FY 2022 · Dec 31, 2021 −$743.07K